» Articles » PMID: 24989446

Nanotechnology-based Strategies for the Detection and Quantification of MicroRNA

Overview
Journal Chemistry
Specialty Chemistry
Date 2014 Jul 4
PMID 24989446
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are important regulators of gene expression, and many pathological conditions, including cancer, are characterized by altered miRNA expression levels. Therefore, accurate and sensitive quantification of miRNAs may result in correct disease diagnosis establishing these small noncoding RNA transcripts as valuable biomarkers. Aiming at overcoming some limitations of conventional quantification strategies, nanotechnology is currently providing numerous significant alternatives to miRNA sensing. In this review an up-to-date account of nanotechnology-based strategies for miRNA detection and quantification is given. The topics covered are: nanoparticle-based approaches in solution, sensing based on nanostructured surfaces, combined nanoparticle/surface sensing approaches, and single-molecule approaches.

Citing Articles

Acoustic separation and concentration of exosomes for nucleotide detection: ASCENDx.

Naquin T, Canning A, Gu Y, Chen J, Naquin C, Xia J Sci Adv. 2024; 10(10):eadm8597.

PMID: 38457504 PMC: 10923504. DOI: 10.1126/sciadv.adm8597.


miRNA probe integrated biosensor platform using bimetallic nanostars for amplification-free multiplexed detection of circulating colorectal cancer biomarkers in clinical samples.

Canning A, Chen X, Li J, Jeck W, Wang H, Vo-Dinh T Biosens Bioelectron. 2022; 220:114855.

PMID: 36332335 PMC: 9881606. DOI: 10.1016/j.bios.2022.114855.


A Combinational Approach for More Efficient miRNA Biosensing.

Lee C Curr Genomics. 2022; 23(1):5-25.

PMID: 35814939 PMC: 9199536. DOI: 10.2174/1389202923666220204160912.


Role of Nano-miRNAs in Diagnostics and Therapeutics.

Coradduzza D, Bellu E, Congiargiu A, Pashchenko A, Amler E, Necas A Int J Mol Sci. 2022; 23(12).

PMID: 35743278 PMC: 9223810. DOI: 10.3390/ijms23126836.


DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis.

Kshirsagar P, Seshacharyulu P, Muniyan S, Rachagani S, Smith L, Thompson C Nanomedicine. 2022; 43:102566.

PMID: 35569810 PMC: 9942096. DOI: 10.1016/j.nano.2022.102566.